Medindia
Advertisement

Drugs Used for ADHD may Not Produce Cardiac Damage

by Ramya Rachamanti on January 4, 2019 at 11:11 AM

Drugs Used for ADHD may Not Produce Cardiac Damage
Around 1.8 million children in the U.S. were taking drugs for attention deficit hyperactivity disorder (ADHD) annually. Effect of these drugs on their hearts has been a cause of concern for parents and physicians. But the results of a long-term National Institutes of Health (NIH)-funded study published in Pediatric Research allay many of these concerns.

The authors caution that because the study was conducted on primates, the findings are not automatically applicable to humans. However, they have previously published that this primate model reliably shows other side effects similar to what is found in children receiving these medications.
Advertisement


Their new findings conclude that chronic exposure to methylphenidate (MPH), a commonly prescribed ADHD drug, is unlikely to increase cardiovascular risks in healthy children.

"The findings are very reassuring in that even high-dose chronic MPH stimulant therapy did not result in any evidence of abnormal structures or function in the hearts of the monkeys," said Steven E. Lipshultz, MD, the study's principal investigator, and senior and corresponding author, who is the A. Conger Goodyear Professor and Chair of the Department of Pediatrics in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. He also is the pediatric chief-of-service at Kaleida Health; medical director, pediatrics services business development, for John R. Oishei Children's Hospital; and president of UBMD Pediatrics.
Advertisement

The research was conducted while Lipshultz was the Batchelor Chair of Pediatrics and director of the Batchelor Children's Research Institute at the University of Miami Miller School of Medicine, and later while he was the Carman and Ann Adams Endowed Chair of Pediatric Research at Wayne State University School of Medicine and Children's Hospital of Michigan.

Sudden cardiac death controversy

The results contribute important evidence to an ongoing controversy about whether or not MPH is associated with sudden cardiac death. A number of studies have reported an increase in sudden cardiac death or other damage to the heart in some children taking the drug or other stimulant therapy for ADHD.

With ADHD and related disorders diagnosed in about 10 percent of all children in the U.S., and with as many as 70 percent of these children receiving stimulant prescription therapy, the question of possible cardiac risks has emerged as a major public health concern, Lipshultz said.

In response, the U.S. Food and Drug Administration (FDA) has issued a "black box warning" on the drug packaging of some prescription stimulants, noting that children with underlying heart disease should use these medications with caution. Canadian authorities temporarily removed a stimulant drug from use only to reintroduce it, based on the small number of sudden cardiac death events identified through voluntary reporting.

"This controversy has persisted without answer," said Lipshultz. "Yet the number of prescriptions for these medications for children with ADHD continues to expand."

For that reason, about a decade ago, Lipshultz was interested to learn of a U.S. government research project involving 30 male rhesus monkeys that had been receiving daily chronic stimulant therapy with MPH. He noted that the monkeys were carefully maintained and ethically cared for at the FDA's National Center for Toxicological Research in Jefferson, Arkansas.

"I thought they could also shed some light on this charged medical issue related to the safety of chronic stimulant therapy with regard to children's heart health," he said.

Long-term testing

With funding from the NIH and FDA, Lipshultz and his colleagues spent several years developing infrastructure to test how the therapy affected the hearts of these monkeys over the long term. Specialized cardiac catheterization and echocardiography labs were developed at the primate center at the National Center for Toxicological Research where a pediatric interventional cardiologist and a specialist in randomized studies, both on temporary leave from their hospital posts, conducted this study.

For five years, the monkeys were continuously treated with therapeutic, super-therapeutic (high doses) or a placebo, using a randomized design, starting when they were about 2 years old. The duration of the study corresponds to what would be a childhood to adulthood span, the researchers said.

"For ethical reasons, this study could not have been done in children," said Lipshultz.

After comprehensive cardiovascular assessment in all the monkeys, there were no statistical differences between the three groups on serum cardiovascular and inflammatory biomarkers, electrocardiograms, echocardiograms, cardiac pathology from endomyocardial biopsies and other clinical parameters.

The single difference of statistical significance was that elevated levels of mean serum myoglobin were found in the lower-dose group. This protein, found in skeletal and cardiac muscle, can be a sign of skeletal muscle injury when found in the serum of humans who have not sustained cardiac injury. Primates in the group receiving high-dose therapy had lower, but still significantly elevated levels.

Because there was no clinical or laboratory evidence of significant cardiac disease in the animals, the authors concluded the elevated myoglobin levels most likely originated in skeletal muscle and were unrelated to a cardiac effect.

In addition to the large population of children being treated with this therapy for ADHD and related disorders, Lipshultz noted that the findings also are good news for child survivors of cancer.

"On a personal level, I have cared for children and adolescents who have survived childhood cancer, who now are experiencing severe learning disabilities as a result of their cancer therapies," he said. "They become my patients because their hearts have been damaged, an unfortunate effect of the successful treatment of their childhood cancer.

"Current recommendations state that children, such as these, with underlying heart disease should avoid chronic stimulant therapy because of the concern that it could further damage their hearts. However, these prescription stimulants often allow these children to do much better with their learning progress, and denying such a useful therapy for theoretical reasons is difficult. The findings that we are reporting demonstrate that these useful medications, in many cases, can be prescribed to these children as well."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Dyslexia Attention Deficit Hyperactivity Disorder (ADHD) Palpitations And Arrhythmias Bullying at School - Tips For Schools ADHD Dyscalculia / Learning Disabilities Statins Drugs Banned in India Cardiomyopathy 
Recommended Reading
Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD) is a neurobiological disorder that affects normal be...
Cardiomyopathy
Cardiomyopathy weakens the heart muscles and the heart loses strength to pump blood throughout the b...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Dyscalculia / Learning Disabilities
Dyscalculia is a learning disability involving mathematics. Recognized by The WHO, it affects nearl...
Dyslexia
Dyslexia is a reading disability that occurs when the brain does not properly recognize and process ...
Palpitations And Arrhythmias
Palpitations are unpleasant sensation of one’s own heartbeat....
Statins
Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms bu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use